A metabolic helper A cellular recycler ALA helps regenerate other antioxidants like vitamins C and E, as well as glutathione
A 2026 Washington University School of Medicine analysis of veterans with type 2 diabetes found that even brief interruptions of GLP-1 treatment -- as little as six months -- were associated with higher risk of heart attack, stroke, and death compared with continuous use
The study followed patients from the start of treatment use to an outcome event defined as emigration, death, or end of study period
Long-term success in weight management and improvement in conditions like OSA requires a comprehensive approach
The Research Behind Foundayo, Explained Foundayo's FDA approval was supported by the ATTAIN clinical trial program , a large-scale Phase 3 study that evaluated its safety and efficacy in adults with obesity or overweight across two global trials
Yes, oral semaglutide is a prescription GLP-1 receptor agonist approved for type 2 diabetes